NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
31/12/2024
Voltar para busca
Dado oficial do USPTO
CUROGEN
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: Estados Unidos
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
36
Atualização mais recente
31/12/2024
Tipo de marca
Verbal
Classes Nice
5, 42
Data de depósito
17/11/2021
Data de registro
31/12/2024
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
31/12/2024
Última transação
31/12/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Código do desenho
4
Tipo de titular
99
Localização do titular
Gyeonggi-do, KR
Examinador
MOSCATI, JUSTIN
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
CUROGEN Technology Co., Ltd.
Representantes
Steven John Hultquist HULTQUIST, PLLC
Classificação técnica
Classes Nice
Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
pharmaceutical preparations for diagnosis; diagnostic agents for pharmaceutical use; pharmaceutical preparations for the prevention of autoimmune diseases; pharmaceutical preparations for the treatment of auto-immune diseases; monoclonal antibodies for medical purposes; polyclonal antibodies for medical purposes; compounds for treating cancer; biological preparations for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; chemical preparations for pharmaceutical purposes for the treatment of cancer or autoimmune diseases; immunoassay reagents for medical use; biological preparations for medical purposes for the treatment of cancer or autoimmune diseases; chemico-pharmaceutical preparations for the treatment of cancer or autoimmune diseases; preparations of microorganisms for medical purposes; pharmaceuticals for the treatment of cancer or autoimmune diseases; pharmaceutical compositions for the treatment of cancer or autoimmune diseases
Classe 42
pharmaceutical drug development services; research on the subject of pharmaceuticals; pharmaceutical drug development services; medicine research; analysis and evaluation of medical product development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing information on medical research being testinginspectionresearch of medical products; evaluating of clinical trial progress; development of biologics; research of biologics; biological research and analysis; drug discovery services; conducting clinical trials for others; scientific research; clinical trials; biological laboratory services; laboratory research in the field of chemistry; laboratory analysis in the field of chemistry; research and development of new products for others; pharmaceutical research and development
Publicações
Histórico de despachos e eventos da marca no USPTO.
36 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
31/12/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/11/2024
PUBO
PUBLISHED FOR OPPOSITION
12/11/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
23/10/2024
OTHE
CASE RETURNED TO EXAMINATION
04/10/2024
IUCN
NOTICE OF ALLOWANCE CANCELLED
04/10/2024
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
03/10/2024
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
03/10/2024
APET
ASSIGNED TO PETITION STAFF
30/09/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/09/2024
EX2G
SOU EXTENSION 2 GRANTED
11/09/2024
EXT2
SOU EXTENSION 2 FILED
11/09/2024
EEXT
SOU TEAS EXTENSION RECEIVED
11/09/2024
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
11/09/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/03/2024
EX1G
SOU EXTENSION 1 GRANTED
06/03/2024
EXT1
SOU EXTENSION 1 FILED
06/03/2024
EEXT
SOU TEAS EXTENSION RECEIVED
06/03/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
19/09/2023
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
06/08/2023
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
26/04/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
28/03/2023
PUBO
PUBLISHED FOR OPPOSITION
28/03/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/03/2023
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
31/01/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
17/01/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/01/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/01/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/01/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
29/08/2022
GNRT
NON-FINAL ACTION E-MAILED
29/08/2022
CNRT
NON-FINAL ACTION WRITTEN
29/08/2022
DOCK
ASSIGNED TO EXAMINER
29/08/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
23/11/2021
NWAP
NEW APPLICATION ENTERED
20/11/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CUROGEN ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.